|
1
|
de Bessa Garcia SA, Araujo M, Pereira T,
Mouta J and Freitas R: HOX genes function in breast cancer
development. Biochim Biophys Acta Rev Cancer. 1873:1883582020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu Y, Yin W, Yu ZH, Zhou YJ, Chi JR, Ge J
and Cao XC: miR-190 enhances endocrine therapy sensitivity by
regulating SOX9 expression in breast cancer. J Exp Clin Cancer Res.
38:222019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spronk I, Schellevis FG, Burgers JS, de
Bock GH and Korevaar JC: Incidence of isolated local breast cancer
recurrence and contralateral breast cancer: A systematic review.
Breast. 39:70–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abdollahzadeh R, Daraei A, Mansoori Y,
Sepahvand M, Amoli MM and Tavakkoly-Bazzaz J: Competing endogenous
RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A
new look at hallmarks of breast cancer. J Cell Physiol.
234:10080–10100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han P and Chang CP: Long non-coding RNA
and chromatin remodeling. RNA Biol. 12:1094–1098. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Parolia A, Venalainen E, Xue H, Mather R,
Lin D, Wu R, Pucci P, Rogalski J, Evans JR, Feng F, et al: The long
noncoding RNA HORAS5 mediates castration-resistant prostate cancer
survival by activating the androgen receptor transcriptional
program. Mol Oncol. 13:1121–1136. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thapar R, Wang JL, Hammel M, Ye R, Liang
K, Sun C, Hnizda A, Liang S, Maw SS, Lee L, et al: Mechanism of
efficient double-strand break repair by a long non-coding RNA.
Nucleic Acids Res. 48:10953–10972. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Simko EAJ, Liu H, Zhang T, Velasquez A,
Teli S, Haeusler AR and Wang J: G-quadruplexes offer a conserved
structural motif for NONO recruitment to NEAT1 architectural
lncRNA. Nucleic Acids Res. 48:7421–7438. 2020.PubMed/NCBI
|
|
10
|
Zhang XZ, Liu H and Chen SR: Mechanisms of
long non-coding RNAs in cancers and their dynamic regulations.
Cancers (Basel). 12:12452020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang X, Xiao R, Pan S, Yang X, Yuan W, Tu
Z, Xu M, Zhu Y, Yin Q, Wu Y, et al: Uncovering the roles of long
non-coding RNAs in cancer stem cells. J Hematol Oncol. 10:622017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prabhu KS, Raza A, Karedath T, Raza SS,
Fathima H, Ahmed EI, Kuttikrishnan S, Therachiyil L, Kulinski M,
Dermime S, et al: Non-coding RNAs as regulators and markers for
targeting of breast cancer and cancer stem cells. Cancers (Basel).
12:3512020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu J, Li M and Zhang Y: Long noncoding RNA
HOXA-AS2 regulates the expression of SCN3A by sponging miR-106a in
breast cancer. J Cell Biochem. 120:14465–14475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Orellana EA, Li C, Lisevick A and Kasinski
AL: Identification and validation of microRNAs that synergize with
miR-34a-a basis for combinatorial microRNA therapeutics. Cell
Cycle. 18:1798–1811. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Witwer KW and Halushka MK: Toward the
promise of microRNAs-enhancing reproducibility and rigor in
microRNA research. RNA Biol. 13:1103–1116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen Q, Xu Z, Sun G, Wang H and Zhang L:
LINC01342 silencing upregulates microRNA-508-5p to inhibit
progression of lung cancer by reducing cysteine-rich secretory
protein 3. Cell Death Discov. 7:2382021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shang Y, Zhang Z, Liu Z, Feng B, Ren G, Li
K, Zhou L, Sun Y, Li M, Zhou J, et al: miR-508-5p regulates
multidrug resistance of gastric cancer by targeting ABCB1 and
ZNRD1. Oncogene. 33:3267–3276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ganini C, Amelio I, Bertolo R, Bove P,
Buonomo OC, Candi E, Cipriani C, Daniele ND, Juhl H, Mauriello A,
et al: Global mapping of cancers: The cancer genome atlas and
beyond. Mol Oncol. 15:2823–2840. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiao K, Ning S, Wan L, Wu H, Wang Q, Zhang
X, Xu S and Pang D: Correction to: LINC00673 is activated by YY1
and promotes the proliferation of breast cancer cells via the
miR-515-5p/MARK4/Hippo signaling pathway. J Exp Clin Cancer Res.
39:1542020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan G, Mao A, Liu J, Lu J, Ding J and Liu
W: Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast
cancer progression through targeting miR-326/TFF1 signalling. Cell
Prolif. 53:e127202020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dang L, Wang Y, Shi C, Liao M, Sun Z and
Fang S: A potential tumor suppressor gene named miR-508-5p
inhibited the proliferation and invasion of human melanoma cells by
targeting KIT. Technol Cancer Res Treat. 19:15330338209518012020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu YH, Li B, Meng FG and Qiu L:
MiR-508-5p is a prognostic marker and inhibits cell proliferation
and migration in glioma. Eur Rev Med Pharmacol Sci. 21:76–81.
2017.PubMed/NCBI
|
|
24
|
Wu SG, Huang YJ, Bao B, Wu LM, Dong J, Liu
XH, Wang XY, Wang L, Chen BJ and Chen W: miR-508-5p acts as an
anti-oncogene by targeting MESDC1 in hepatocellular carcinoma.
Neoplasma. 64:40–47. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang B, Zheng J, Li R, Tian Y, Lin J,
Liang Y, Sun Q, Xu A, Zheng R, Liu M, et al: Long noncoding RNA
LINC02582 acts downstream of miR-200c to promote radioresistance
through CHK1 in breast cancer cells. Cell Death Dis. 10:7642019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S, Liang K, Hu Q, Li P, Song J, Yang
Y, Yao J, Mangala LS, Li C, Yang W, et al: JAK2-binding long
noncoding RNA promotes breast cancer brain metastasis. J Clin
Invest. 127:4498–4515. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y and Cai X: Long noncoding RNA
HAND2-AS1 restrains proliferation and metastasis of breast cancer
cells through sponging miR-1275 and promoting SOX7. Cancer Biomark.
27:85–94. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong J, He M, Li J, Pessentheiner AR, Wang
C, Zhang J, Sun Y, Wang WT, Zhang Y, Liu J, et al: MicroRNA-483
ameliorates hypercholesterolemia by inhibiting PCSK9 production.
JCI Insight. 5:e1438122020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li M, Cui X and Guan H: MicroRNAs: Pivotal
regulators in acute myeloid leukemia. Ann Hematol. 99:399–412.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wichadakul D, Mhuantong W, Jongkaewwattana
A and Ingsriswang S: A computational tool for the design of live
attenuated virus vaccine based on microRNA-mediated gene silencing.
BMC Genomics. 13 (Suppl 7):S152012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liao Y, Peng Z, Chen L, Liu L, Wu Q and
Yang W: Roles of microRNAs and prospective view of competing
endogenous RNAs in mycotoxicosis. Mutat Res Rev Mutat Res.
782:1082852019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang M, Cheng L and Zhang Y:
Characterization of dysregulated lncRNA-associated ceRNA network
reveals novel lncRNAs with ceRNA activity as epigenetic diagnostic
biomarkers for osteoporosis risk. Front Cell Dev Biol. 8:1842020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhuo M, Yuan C, Han T, Cui J, Jiao F and
Wang L: A novel feedback loop between high MALAT-1 and low
miR-200c-3p promotes cell migration and invasion in pancreatic
ductal adenocarcinoma and is predictive of poor prognosis. BMC
Cancer. 18:10322018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang S, Hu Y, Lv X, Li B, Gu D, Li Y, Gu
D, Li Y, Sun Y and Su Y: Circ-0000284 arouses malignant phenotype
of cholangiocarcinoma cells and regulates the biological functions
of peripheral cells through cellular communication. Clin Sci
(Lond). 133:1935–1953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bao G, Wang N, Li R, Xu G, Liu P and He B:
MiR-508-5p inhibits the progression of glioma by targeting
glycoprotein non-metastatic melanoma B. Neurochem Res.
41:1684–1690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Y, Zhao YH, Kalaslavadi TB, Hamati E,
Nehrke K, Le AD, Ann DK and Wu R: Genome-wide search and
identification of a novel gel-forming mucin MUC19/Muc19 in
glandular tissues. Am J Respir Cell Mol Biol. 30:155–165. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu DF, Chen Y, Han JM, Zhang H, Chen XP,
Zou WJ, Liang LY, Xu CC and Liu ZG: MUC19 expression in human
ocular surface and lacrimal gland and its alteration in Sjogren
syndrome patients. Exp Eye Res. 86:403–411. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qiu Z, Wang L and Liu H: Hsa_circ_0001982
promotes the progression of breast cancer through miR-1287-5p/MUC19
axis under hypoxia. World J Surg Oncol. 19:1612021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Song L and Xiao Y: Downregulation of
hsa_circ_0007534 suppresses breast cancer cell proliferation and
invasion by targeting miR-593/MUC19 signal pathway. Biochem Biophys
Res Commun. 503:2603–2610. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Y, Zhang Q, Wu J, Zhang H, Li X, Zheng
Z, Luo M, Li L, Xiang Y, Yang F and Wu L: Long non-coding RNA
A2M-AS1 promotes breast cancer progression by sponging
microRNA-146b to upregulate MUC19. Int J Gen Med. 13:1305–1316.
2020. View Article : Google Scholar : PubMed/NCBI
|
